37-Year Mesothelioma Survivor Credits Immunotherapy – Asbestos.com (blog)
|
37-Year Mesothelioma Survivor Credits Immunotherapy
Asbestos.com (blog) Although the theory behind the treatment was a precursor to today’s more accepted immunotherapy, IAT worked outside any regulation or oversight from the U.S. medical community. Established oncologists often scoffed at mention of the clinic, and there … |
|
Wed 8:30 | Stem Cell Therapy For You And For Fido
Jefferson Public Radio Wed 8:30 | Stem Cell Therapy For You And For Fido. By Geoffrey Riley, April Ehrlich & John Baxter • 2 minutes ago. Related Program: The Jefferson Exchange · TweetShareGoogle+Email. Wikimedia Commons user order_242. You’ve heard plenty about research … |
|
Genetic Rx panel on gene therapy regulatory strategies led by Renova Therapeutics CEO and Co-founder
PR Newswire (press release) The company’s lead product candidate, RT-100, is a treatment that delivers a therapeutic gene directly to the heart during a routine outpatient procedure and has the potential to increase heart function in millions of patients with heart failure. The … |
Penn Current |
Bringing Synthetic Biology to High School Students
Penn Current Penn professors are collaborating to bring the new field of synthetic biology into Philadelphia high schools. The Graduate School of Education’s Yasmin Kafai and the School of Design’s Orkan Telhan are developing affordable, safe, and user-friendly … |
|
New Scientific Publication Supports Agilvax’s Novel Immunotherapy …
Business Wire (press release) Agilvax has published preclinical data regarding its immunotherapy candidate, AX09, for metastatic breast cancer in the journal OncoImmunology. |